Published in Euro Surveill on January 17, 2013
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev (2014) 2.45
Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis (2015) 1.27
Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol (2014) 1.19
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother (2013) 1.11
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins. BMC Infect Dis (2014) 1.05
Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. Microbiol Spectr (2016) 0.98
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011. BMC Infect Dis (2013) 0.95
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study. Lancet Infect Dis (2016) 0.93
Population and Functional Genomics of Neisseria Revealed with Gene-by-Gene Approaches. J Clin Microbiol (2016) 0.93
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012. BMC Infect Dis (2014) 0.92
Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins. Emerg Infect Dis (2014) 0.89
Distribution and diversity of the haemoglobin-haptoglobin iron-acquisition systems in pathogenic and non-pathogenic Neisseria. Microbiology (2013) 0.88
Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013. BMC Infect Dis (2015) 0.85
Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins. Eur J Clin Microbiol Infect Dis (2016) 0.83
Utility of specimens positive for Neisseria gonorrhoeae by the Aptima Combo 2 assay for assessment of strain diversity and antibiotic resistance. J Clin Microbiol (2013) 0.80
The world's microbiology laboratories can be a global microbial sensor network. Biomedica (2014) 0.79
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother (2016) 0.77
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012. Antimicrob Agents Chemother (2014) 0.77
Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan. BMC Infect Dis (2015) 0.77
Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA. BMC Infect Dis (2013) 0.77
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae. BMC Microbiol (2015) 0.76
First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009-2013. New Microbes New Infect (2014) 0.76
Increasing Incidence of High-Level Tetracycline-Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import. Yonsei Med J (2016) 0.75
Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan. BMC Infect Dis (2016) 0.75
Draft Genome Sequence of Neisseria gonorrhoeae Sequence Type 1407, a Multidrug-Resistant Clinical Isolate. Genome Announc (2015) 0.75
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary. Ann Clin Microbiol Antimicrob (2016) 0.75
PenA, ponA, porB1 and mtrR mutations and molecular epidemiological typing of Neisseria gonorrhoeae with decreased susceptibility to cephalosporin. Antimicrob Agents Chemother (2017) 0.75
Rise in gonorrhoea in London, UK. London Gonococcal Working Group. Lancet (2000) 4.08
Declining incidence of gonorrhoea in London: a response to fear of AIDS? Lancet (1986) 3.64
Roles of yeast DNA polymerases delta and zeta and of Rev1 in the bypass of abasic sites. Genes Dev (2001) 3.59
Longer delays in tuberculosis diagnosis among women in Vietnam. Int J Tuberc Lung Dis (1999) 3.30
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS (2013) 2.44
Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob Agents Chemother (1998) 2.41
Male carriage of Gardnerella vaginalis. Br J Vener Dis (1982) 2.30
Emergence of resistance after spectinomycin treatment for gonorrhoea due to beta-lactamase producing strain of Neisseria gonorrhoeae. Br Med J (Clin Res Ed) (1982) 2.29
Fear and social isolation as consequences of tuberculosis in VietNam: a gender analysis. Health Policy (2001) 2.12
Opa-typing: a high-resolution tool for studying the epidemiology of gonorrhoea. Mol Microbiol (1995) 1.86
Sexual partner networks in the transmission of sexually transmitted diseases. An analysis of gonorrhea cases in Sheffield, UK. Sex Transm Dis (1997) 1.82
Regression of warts. An immunological study. Lancet (1975) 1.78
Penicillinase producing gonococci: a spent force? Genitourin Med (1986) 1.75
A real-time quadriplex PCR assay for the diagnosis of rectal lymphogranuloma venereum and non-lymphogranuloma venereum Chlamydia trachomatis infections. Sex Transm Infect (2008) 1.70
Introduction and summary tables. Sex Transm Infect (2006) 1.68
The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--national resistance prevalence in 2007 and 2008, and trends during 2005-2008. Euro Surveill (2010) 1.66
Application of the stretched exponential function to fluorescence lifetime imaging. Biophys J (2001) 1.62
Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Euro Surveill (2012) 1.62
Involvement of the gonococcal MtrE protein in the resistance of Neisseria gonorrhoeae to toxic hydrophobic agents. Microbiology (1997) 1.61
A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS (1997) 1.56
2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol (2014) 1.54
Associations between serotype and susceptibility to antibiotics of Neisseria gonorrhoeae. Genitourin Med (1989) 1.52
Interactions between the Werner syndrome helicase and DNA polymerase delta specifically facilitate copying of tetraplex and hairpin structures of the d(CGG)n trinucleotide repeat sequence. J Biol Chem (2001) 1.50
Comparison of culture and microscopy in the diagnosis of Gardnerella vaginalis infection. J Clin Pathol (1982) 1.50
Prevalence of black-pigmented bacteroides species in root canal infections. J Endod (1989) 1.49
Scientific rigour in qualitative research--examples from a study of women's health in family practice. Fam Pract (1994) 1.44
Different tuberculosis in men and women: beliefs from focus groups in Vietnam. Soc Sci Med (1999) 1.43
Circinate erosive balanitis and HL-A 27. Acta Derm Venereol (1975) 1.42
Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect (2007) 1.42
Functional interaction between the Werner Syndrome protein and DNA polymerase delta. Proc Natl Acad Sci U S A (2000) 1.42
Lymphogranuloma venereum in the United Kingdom. Sex Transm Infect (2005) 1.40
Evaluation of the discriminatory power of typing methods for Neisseria gonorrhoeae. J Clin Microbiol (1999) 1.39
Identification of the znuA-encoded periplasmic zinc transport protein of Haemophilus ducreyi. Infect Immun (1999) 1.39
Homology of cryptic plasmid of Neisseria gonorrhoeae with plasmids from Neisseria meningitidis and Neisseria lactamica. J Clin Pathol (1986) 1.38
The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study. Sex Transm Infect (2009) 1.37
A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol (1994) 1.35
Two new male contraceptives exert their effects by depleting germ cells prematurely from the testis. Biol Reprod (2001) 1.34
GroEL heat shock protein of Haemophilus ducreyi: association with cell surface and capacity to bind to eukaryotic cells. Infect Immun (1998) 1.32
A longitudinal study of pelvic inflammatory disease. Br J Obstet Gynaecol (1992) 1.32
Recent trends in gonorrhoea and syphilis epidemiology in Sweden: 2007 to 2011. Euro Surveill (2012) 1.32
Spectinomycin as initial treatment for gonorrhoea. Br Med J (Clin Res Ed) (1984) 1.26
Tetracycline-resistant gonococci in UK. Lancet (1988) 1.26
A prospective social and molecular investigation of gonococcal transmission. Lancet (2000) 1.24
Gonorrhea, genital chlamydial infection, and nonspecific urethritis in male partners of women hospitalized and treated for acute pelvic inflammatory disease. Sex Transm Dis (1993) 1.24
Neisseria gonorrhoeae isolated at St. Mary's Hospital London, 1980-91. Genitourin Med (1993) 1.24
Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother (2009) 1.21
Spectinomycin resistant gonococci. Br Med J (Clin Res Ed) (1983) 1.21
Naturally occurring isolates of Neisseria gonorrhoeae, which display anomalous serovar properties, express PIA/PIB hybrid porins, deletions in PIB or novel PIA molecules. FEMS Microbiol Lett (1998) 1.19
Antimicrobial sensitivity of Neisseria gonorrhoeae. Comparison of penicillinase producing and non-penicillinase producing strains. Br J Vener Dis (1983) 1.17
Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect Immun (2001) 1.17
Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol (1984) 1.17
The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis (1996) 1.16
European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother (2006) 1.15
Missing cruciate ligament in congenital short femur. J Bone Joint Surg Am (1983) 1.14
P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol Microbiol (1999) 1.14
Bactericidal effect of pooled human serum on Bacteroides melaninogenicus, Bacteroides asaccharolyticus and Actinobacillus actinomycetemcomitans. Scand J Dent Res (1982) 1.14
Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol (1998) 1.13
Subject-specific, multiscale simulation of electrophysiology: a software pipeline for image-based models and application examples. Philos Trans A Math Phys Eng Sci (2009) 1.12
Community perceptions of tuberculosis: A qualitative exploration from a gender perspective. Public Health (2011) 1.12
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect (2009) 1.12
Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect (2007) 1.11
Non-volatile fatty acids in the diagnosis of non-specific vaginitis. J Clin Pathol (1983) 1.11
Variation within serovars of Neisseria gonorrhoeae detected by structural analysis of outer-membrane protein PIB and by pulsed-field gel electrophoresis. Microbiology (1997) 1.11
A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity. J Med Chem (2001) 1.10
A typing system for neisseria gonorrhoeae based on biotinylated oligonucleotide probes to PIB gene variable regions. J Infect Dis (2000) 1.10
Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. APMIS (2001) 1.09
Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids (2000) 1.09
Classification of fungi by means of pyrolysis-gas chromatography-pattern recognition. J Chromatogr (1979) 1.08
Penicillinase-producing Neisseria gonorrhoeae. N Engl J Med (1982) 1.08
Gonorrhoea. Sex Transm Infect (2006) 1.07
Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis. Br J Vener Dis (1982) 1.06
Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev (2002) 1.05
Vaginitis revisited. Br Med J (Clin Res Ed) (1981) 1.05
Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene (2010) 1.04
Molecular epidemiology of syphilis in Scotland. Sex Transm Infect (2009) 1.04
Phagocytosis of Bacteroides melaninogenicus and Bacteroides gingivalis in vitro by human neutrophils. J Periodontal Res (1982) 1.03
The effect of media on antimicrobial susceptibility testing of Neisseria gonorrhoeae. J Antimicrob Chemother (1988) 1.03
The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis. Sex Transm Infect (2005) 1.03
Three-dimensional structure of a mammalian purple acid phosphatase at 2.2 A resolution with a mu-(hydr)oxo bridged di-iron center. J Mol Biol (1999) 1.02
Current status of serotyping of Neisseria gonorrhoeae. Eur J Epidemiol (1990) 1.02
Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog (1999) 1.02
Classes of antibodies in acute gonorrhoea. Lancet (1979) 1.00
Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques. J Virol (2004) 1.00
Evaluation of the new COBAS TaqMan CT test v2.0 and impact on the proportion of new variant Chlamydia trachomatis by the introduction of diagnostics detecting new variant C trachomatis in Orebro county, Sweden. Sex Transm Infect (2008) 1.00
Results of a Europe-wide investigation to assess the presence of a new variant of Chlamydia trachomatis. Euro Surveill (2007) 0.99
Detection of mixed infection of Neisseria gonorrhoeae. Sex Transm Infect (2003) 0.99
Enzyme-linked immunosorbent assay (ELISA) to detect antibodies in gonorrhea using whole cells. J Clin Pathol (1981) 0.99
Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants. Pediatr Infect Dis J (2001) 0.99
Naturally occurring PIA/PIB hybrids of Neisseria gonorrhoeae. FEMS Microbiol Lett (1994) 0.99
Bacterial vaginosis: a diagnostic approach. Genitourin Med (1992) 0.98
Arginine-, hypoxanthine-, uracil-requiring isolates of Neisseria gonorrhoeae are a clonal lineage with a non-clonal population. Microbiology (1997) 0.98
Risk factors associated with asthma and rhinoconjunctivitis among Swedish farmers. Allergy (1999) 0.98
Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Euro Surveill (2014) 0.97
The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill (2011) 0.97
Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin Microbiol Infect (2009) 0.97
Evaluation of a direct immunofluorescence test for diagnosing gonorrhoea. J Clin Pathol (1985) 0.96
Plasmids in throat and genital isolates of meningococci. J Clin Pathol (1984) 0.96
Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes. Cancer Chemother Pharmacol (1980) 0.96